Lipid peroxides are oxygen fragments that are generated as a by-product of free-radical production and the measurement of their level in the urine is a well-documented method for estimating antioxidant sufficiency.

Most cells in your body are surrounded by a fat (lipid) layer. It is this layer that is attacked and damaged by free radicals when the body's antioxidant quenching systems are not working up to par. This can result in cell death or cell mutation. High lipid peroxides in the urine can mean that your lifestyle is putting heavy demands on your antioxidant quenching system; in other words, you are under increased oxidant stress. You need extra antioxidant support.

The VAP Test provides all the information found in a routine lipid panel, plus measurements of all known cholesterol subclasses that play important roles in the development of CAD. The additional information provided by the VAP Test improves the ability to predict heart disease risk to more than 90%. It also directly measures LDL cholesterol. In contrast, the routine cholesterol test detects only about 40% of people at risk.

The NCEP ATP III guidelines offer new opportunities to improve the early detection and treatment of heart disease. ATP III focuses attention on the metabolic syndrome, as well as several emerging risk factors and secondary targets of therapy that are not measured with the routine lipid panel. The VAP Test allows clinicians to comply with ATP III at a cost comparable to the routine lipid panel.

Cholesterol and Triglyceride tests that measure the total amount of fatty substances in the blood. Lipoprotein analysis (lipid profile) measures blood levels of total cholesterol, LDL (bad) cholesterol and HDL (good) cholesterol and triglycerides.

Despite the epidemiological studies which failed to detect any relationship between total cholesterol levels in plasma and the risk of stroke in the elderly [Prospective Studies Collaboration, 1995; Neaton et al., 1992; Sacco et al., 1997], two series of evidence support a role for cholesterol in the development of stroke.

Answer: WETSEM® technology allows analysis of lipid structures in an unperturbed state. The ability to image wet samples with SEM avoids the problem of lipid extraction that occurs due to dehydration with organic solvents during lipid imaging with conventional techniques. Many lipid structures are visualized without any enhancement. If staining is required, Osmium tetroxide is well suited for lipids; for detailed protocols, see the QX-102 User Manual.

The fatty acids are reported as grams of fatty acid per 100 grams of food. They may not add up to the total lipid value provided in a database because the fat value may include some non-fatty acid material, such as, glycerol, phosphate, sugar or sterol. In the case of vegetable oils that are 100% triglyceride, 95.6% is fatty acid and the remaining 4.4% is glycerol. For other fats, the percent of fatty acid will be even lower.

Liposomal encapsulation or incorporation into a lipid complex can substantially affect a drug's functional properties relative to those of the unencapsulated drug or non-lipid associated drug. In addition, different liposomal or lipid-complex products with a common active ingredient may vary from one another in the chemical composition and physical form of the lipid component. Such differences may affect the functional properties of these drug products.

The Lipid Profile•ALT test is run using the same procedure as that for lipids and glucose with the following exception: There is a separate Cholestech control available for use with the Lipid Profile•ALT test cassette. You must use the Lipid Profile•ALT Control when running the Lipid Profile•ALT test.

Assays for ALT and AST may be run at commercial clinical laboratories at different temperatures, typically 30°C or 37°C. The Cholestech LDX ALT•AST test is run at 37°C.

Answer: WETSEM™ technology allows analysis of lipid structures in an unperturbed state. The ability to image wet samples with SEM avoids the problem of lipid extraction that occurs due to dehydration with organic solvents during lipid imaging with conventional techniques. Many lipid structures are visualized without any enhancement. If staining is required, Osmium tetroxide is well suited for lipids; for detailed protocols, see the QX-102 User Manual.

There are a variety of products we carry that fall into this category, including CholestePure, EPA/DHA essentials, Pantethine, Policosanol, Pantethine/Policosanol, Niacitol, Guggul, Sytrinol, UltraHeart, Garlic, Fenugreek 85, Tocotrienols, LinumLife and IsoProtein Plus.

David Gaist, Luis Alberto Garc?a Rodr?guez ? Consuelo Huerta ? Jesper Hallas ? S?ren H. Sindrup http://213.4.18.135/75.pdf full text

Since a large proportion of strokes are due to atherosclerotic processes, more attention is needed to identify subjects at high risk of developing cardiovascular events. In Europe and other countries, guidelines recommend a global multifactorial assessment and management of cardiovascular risks [Pyorala et al., 1994].